JOHN W. STOVER, M.D.; ROBERT W. GRIFFIN, M.D.; RALPH V. FORD, M.D.
The aggressive treatment of hypertensive disease has come to occupy a more prominent part in the clinician's interest. This is due to the availability of potent antihypertensive agents. In some instances the enthusiasm of the clinician has been dampened by the observation of increased renal insufficiency accompanying a marked reduction of blood pressure. The occurrence of uremia has been observed more commonly in patients treated with ganglionic blocking agents because: (1) the drugs are quite potent in reducing blood pressure, and (2) the patients requiring treatment with these agents are more likely to have severe hypertensive disease, which is accompanied
STOVER JW, GRIFFIN RW, FORD RV. THE EFFECTS OF CHRONIC PENTAPYRROLIDINIUM-INDUCED HYPOTENSION ON RENAL HEMODYNAMICS AND ON THE EXCRETION OF WATER AND ELECTROLYTES IN HYPERTENSION(THE EFFECTS OF CHRONIC PENTAPYRROLIDINIUM-INDUCED HYPOTENSION ON RENAL HEMODYNAMICS AND ON THE EXCRETION OF WATER AND ELECTROLYTES IN HYPERTENSION*). Ann Intern Med. 1956;44:893–898. doi: 10.7326/0003-4819-44-5-893
Download citation file:
Published: Ann Intern Med. 1956;44(5):893-898.
Cardiology, Coronary Risk Factors, Hypertension, Nephrology.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use